TFM
VRTX icon

TFC Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History

TFC Financial Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Hold
307
– – 0.02% 167
2025
Q4 		$139K Sell
307
-1
-0.3% -$431 0.02% 163
2025
Q3 		$121K Sell
308
-15
-5% -$6.27K 0.02% 175
2025
Q2 		$144K Hold
323
– – 0.02% 156
2025
Q1 		$157K Hold
323
– – 0.02% 142
2024
Q4 		$130K Hold
323
– – 0.02% 161
2024
Q3 		$150K Buy
323
+10
+3% +$4.8K 0.02% 149
2024
Q2 		$147K Buy
313
+162
+107% +$70.3K 0.03% 144
2024
Q1 		$63.1K Buy
151
+1
+0.7% +$423 0.01% 214
2023
Q4 		$61K Hold
150
– – 0.01% 211
2023
Q3 		$52.2K Hold
150
– – 0.01% 215
2023
Q2 		$52.8K Buy
150
+3
+2% +$1.01K 0.01% 216
2023
Q1 		$46.3K Buy
147
+4
+3% +$1.2K 0.01% 236
2022
Q4 		$41.3K Buy
143
+16
+13% +$4.88K 0.01% 211
2022
Q3 		$37K Buy
127
+18
+17% +$5.18K 0.01% 215
2022
Q2 		$31K Buy
109
+40
+58% +$10.7K 0.01% 228
2022
Q1 		$18K Buy
69
+22
+47% +$5.22K 0.01% 270
2021
Q4 		$10K Hold
47
– – ﹤0.01% 340
2021
Q3 		$9K Hold
47
– – ﹤0.01% 345
2021
Q2 		$9K Hold
47
– – ﹤0.01% 330
2021
Q1 		$10K Sell
47
-18
-28% -$3.95K ﹤0.01% 312
2020
Q4 		$15K Sell
65
-4
-6% -$918 0.01% 286
2020
Q3 		$19K Buy
+69
New +$19K 0.01% 238

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TFC Financial Management's VRTX Position: Q1 2026 in Review

TFC Financial Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 307 shares worth $137K. The position accounts for 0.02% of the portfolio, ranked #167.

TFC Financial Management first reported a position in VRTX in Q3 2020 and has held it in 23 quarters since. The position peaked at $157K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • TFC Financial Management held 307 shares of Vertex Pharmaceuticals worth $137K as of Q1 2026.
  • TFC Financial Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.02% of TFC Financial Management's portfolio in Q1 2026, its #167 holding.
  • TFC Financial Management first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • TFC Financial Management's Vertex Pharmaceuticals position peaked at $157K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.